BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9267713)

  • 1. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
    Ahsan N; Holman MJ; Gocke CD; Groff JA; Yang HC
    Clin Transplant; 1997 Aug; 11(4):265-70. PubMed ID: 9267713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.
    Wong TY; Chan PK; Leung CB; Szeto CC; Tam JS; Li PK
    Am J Kidney Dis; 1999 Dec; 34(6):1132-6. PubMed ID: 10585325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature.
    Geetha D; Zachary JB; Baldado HM; Kronz JD; Kraus ES
    Clin Transplant; 2000 Dec; 14(6):586-91. PubMed ID: 11127313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection.
    Choi SH; Chang SP; Won JC; Lee JS; Chi HS; Yang WS; Park SK
    Scand J Infect Dis; 2002; 34(1):71-5. PubMed ID: 11874173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.
    Liefeldt L; Plentz A; Klempa B; Kershaw O; Endres AS; Raab U; Neumayer HH; Meisel H; Modrow S
    J Med Virol; 2005 Jan; 75(1):161-9. PubMed ID: 15543575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parvovirus B19-induced pure red cell aplasia in a liver transplant recipient].
    Lee EY; Cho Y; Lee SG; Song J
    Korean J Lab Med; 2010 Dec; 30(6):591-4. PubMed ID: 21157144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient.
    Shen Q; Xu H; Cao Q; Zhou LJ; Xu J; Fang XY; Ge J
    Pediatr Transplant; 2011 Jun; 15(4):E76-9. PubMed ID: 20136725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parvovirus B19: A Rare Cause of Post-renal Transplant Anemia.
    Ahmed W; Dogar RUH; Acharya S
    J Coll Physicians Surg Pak; 2017 Dec; 27(12):785-787. PubMed ID: 29185410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
    Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atraumatic splenic rupture following IVIg for parvovirus B19 pure red cell aplasia post renal transplant.
    Tiong M; Casan J; McLean C
    Transpl Infect Dis; 2019 Apr; 21(2):e13045. PubMed ID: 30586222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parvovirus B19 infection induced pure red cell aplasia in liver transplant recipients.
    Zhang M; Zhong X; Zhang W; Xu J; Zhang M; Shen Y; Wang W; Zheng S
    Int J Clin Pract Suppl; 2015 May; (183):29-34. PubMed ID: 26177162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe anemia from parvovirus b19 infection in pediatric renal transplant recipients: two case reports.
    Pinto V; Grandy J; Zambrano P; Corta B; Salas P; Salgado I; Santander J; Salgado C; Chadid J; Iñiguez R
    Transplant Proc; 2008 Nov; 40(9):3261-4. PubMed ID: 19010248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Cases of Kidney Transplant Recipients With Multiple Relapsing Pure Red Cell Aplasia Due to Parvovirus B19 Infection.
    Ersal T; Özkalemkaş F; Özkocaman V; Sezen M; Yalçın C; Orhan B; Candar Ö; Çubukçu S; Koca TG
    Exp Clin Transplant; 2024 Jan; 22(1):75-79. PubMed ID: 36259607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment.
    Arzouk N; Snanoudj R; Beauchamp-Nicoud A; Mourad G; Charpentier B; Tchernia G; Durrbach A
    Transpl Int; 2006 Feb; 19(2):166-9. PubMed ID: 16441366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous immunoglobulin--a report of eight patients.
    Koduri PR; Kumapley R; Valladares J; Teter C
    Am J Hematol; 1999 May; 61(1):16-20. PubMed ID: 10331506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic parvovirus B19 infection leading to red cell aplasia following treatment of Hodgkin lymphoma.
    Poplar S; Allford S; Rooney N
    Br J Haematol; 2010 Mar; 148(5):671. PubMed ID: 19681883
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature.
    Crabol Y; Terrier B; Rozenberg F; Pestre V; Legendre C; Hermine O; Montagnier-Petrissans C; Guillevin L; Mouthon L;
    Clin Infect Dis; 2013 Apr; 56(7):968-77. PubMed ID: 23243178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of Pure Red Cell Aplasia in a Kidney Transplant Recipient Due to Reactivation of Parvovirus B19 Infection Despite Two Cycles of Intravenous Immunoglobulin Therapy.
    Kaya B; Paydas S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):195-197. PubMed ID: 30777553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature.
    Liang TB; Li DL; Yu J; Bai XL; Liang L; Xu SG; Wang WL; Shen Y; Zhang M; Zheng SS
    World J Gastroenterol; 2007 Apr; 13(13):2007-10. PubMed ID: 17461508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red-cell aplasia.
    Mouthon L; Guillevin L; Tellier Z
    Autoimmun Rev; 2005 Jun; 4(5):264-9. PubMed ID: 15990072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.